Moomoo AI 已提取核心信息
On February 26, 2024, a Schedule 13G was filed with the United States Securities and Exchange Commission (SEC) by Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander, indicating a significant ownership stake in Altimmune, Inc. The filing, which is a requirement for parties owning more than five percent of a company's stock, shows that the entities collectively hold 2,911,937 shares of Altimmune's common stock, representing 5.4% of the company's class of securities. The shares are held with shared voting and dispositive power. The filing was made under Rule 13d-1(c) of the Securities Exchange Act of 1934, which is used by persons who have acquired the securities for investment purposes and not with the intent of changing or influencing the control of the issuer. The principal executive offices of Altimmune, Inc. are located in Gaithersburg, Maryland. The filing also includes a joint filing agreement dated March 4, 2024, confirming the collaborative nature of the filing among the reporting persons.
On February 26, 2024, a Schedule 13G was filed with the United States Securities and Exchange Commission (SEC) by Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander, indicating a significant ownership stake in Altimmune, Inc. The filing, which is a requirement for parties owning more than five percent of a company's stock, shows that the entities collectively hold 2,911,937 shares of Altimmune's common stock, representing 5.4% of the company's class of securities. The shares are held with shared voting and dispositive power. The filing was made under Rule 13d-1(c) of the Securities Exchange Act of 1934, which is used by persons who have acquired the securities for investment purposes and not with the intent of changing or influencing the control of the issuer. The principal executive offices of Altimmune, Inc. are located in Gaithersburg, Maryland. The filing also includes a joint filing agreement dated March 4, 2024, confirming the collaborative nature of the filing among the reporting persons.
2024年2月26日，千禧管理有限责任公司、千禧集团管理有限责任公司和以色列英格兰德向美国证券交易委员会（SEC）提交了附表13G，表明Altimmune, Inc.拥有大量所有权。该文件要求各方拥有公司5％以上的股份，显示这些实体共持有代表Altimmune普通股的2,911,937股股份，占公司证券类别的5.4％。这些股份以共同的投票权和处置权持有。该文件是根据1934年《证券交易法》第13d-1（c）条提交的，该文件供出于投资目的收购证券且无意改变或影响发行人控制权的人使用。Altimmune, Inc.的主要行政办公室位于马里兰州的盖瑟斯堡。该文件还包括一份日期为2024年3月4日的联合申报协议，该协议确认了申报人之间的合作性质。
2024年2月26日，千禧管理有限责任公司、千禧集团管理有限责任公司和以色列英格兰德向美国证券交易委员会（SEC）提交了附表13G，表明Altimmune, Inc.拥有大量所有权。该文件要求各方拥有公司5％以上的股份，显示这些实体共持有代表Altimmune普通股的2,911,937股股份，占公司证券类别的5.4％。这些股份以共同的投票权和处置权持有。该文件是根据1934年《证券交易法》第13d-1（c）条提交的，该文件供出于投资目的收购证券且无意改变或影响发行人控制权的人使用。Altimmune, Inc.的主要行政办公室位于马里兰州的盖瑟斯堡。该文件还包括一份日期为2024年3月4日的联合申报协议，该协议确认了申报人之间的合作性质。
有用
没用